NEUROCRINE BIOSCIENCES ANNOUNCES INITIATION OF PHASE 1 CLINICAL STUDY EVALUATING NBIP-'1968, A GLP-1/GIP/GLUCAGON RECEPTOR TRIPLE AGONIST

Reuters · 2d ago

Please log in to view news